Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
Titel:
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
Auteur:
Janjigian, Yelena Y Kawazoe, Akihito Bai, Yuxian Xu, Jianming Lonardi, Sara Metges, Jean Phillipe Yanez, Patricio Wyrwicz, Lucjan S Shen, Lin Ostapenko, Yuriy Bilici, Mehmet Chung, Hyun Cheol Shitara, Kohei Qin, Shu-Kui Van Cutsem, Eric Tabernero, Josep Li, Kan Shih, Chie-Schin Bhagia, Pooja Rha, Sun Young